Search research articles
Contact Us
Filters
Showing results (551-560 of 568) with videos related to
Page
of 57
Sort By:
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
June 15, 2025
Psychomotor Development in Infants Following Maternal Exposure to Biologics: Results From the DUMBO Registry
Laura Palomino, Marta Velasco Rodríguez-Belvís, María José Casanova, et al.
Alimentary Pharmacology & Therapeutics
|
June 10, 2026
Real-World Effectiveness of Risankizumab in Refractory Crohn's Disease: The RISANCROHN Study From the ENEIDA Registry
Manuel Barreiro-de Acosta, Yamile Zabana, Laura Nieto-García, et al.
Journal of Clinical Medicine
|
July 29, 2023
Benefits of Paediatric to Adult Transition Programme in Inflammatory Bowel Disease: The BUTTERFLY Study of GETECCU and SEGHNP
Cristina Rubín de Célix, Javier Martín-de-Carpi, Gemma Pujol-Muncunill, et al.
The American Journal of Gastroenterology
|
January 30, 2023
Real-World Evidence of Tofacinitib in Ulcerative Colitis: Short-Term and Long-Term Effectiveness and Safety
María Chaparro, Diana Acosta, Cristina Rodríguez, et al.
United European Gastroenterology Journal
|
December 6, 2025
Comparative Study on the Management and Outcomes of Postoperative Crohn's Disease in Older Patients: Data From the ENEIDA Registry
Míriam Mañosa, Margalida Calafat, Elena Ricart, et al.
Inflammatory Bowel Diseases
|
February 15, 2022
Long-Term Real-World Effectiveness and Safety of Ustekinumab in Crohn's Disease Patients: The SUSTAIN Study
María Chaparro, Iria Baston-Rey, Estela Fernández-Salgado, et al.
Journal of Crohn'S & Colitis
|
May 8, 2019
Clinical Characteristics, Associated Malignancies and Management of Primary Sclerosing Cholangitis in Inflammatory Bowel Disease Patients: A Multicentre Retrospective Cohort Study
Ivan Guerra, Luis Bujanda, Jesús Castro, et al.
Journal of Clinical Medicine
|
August 12, 2022
Using Interpretable Machine Learning to Identify Baseline Predictive Factors of Remission and Drug Durability in Crohn's Disease Patients on Ustekinumab
María Chaparro, Iria Baston-Rey, Estela Fernández Salgado, et al.
Alimentary Pharmacology & Therapeutics
|
August 8, 2025
Frequency and Effectiveness of Dose Escalation and De-Escalation of Biologic Therapy in Inflammatory Bowel Disease: The RAINBOW-IBD Study of ENEIDA
Cristina Rubín de Célix, Elena Ricart, M Dolores Martín-Arranz, et al.
Alimentary Pharmacology & Therapeutics
|
June 29, 2024
Need for therapeutic escalation in patients with refractory ulcerative proctitis: Results from the PROCU study of the ENEIDA registry
Rocío Ferreiro-Iglesias, Sol Porto Silva, Sandra Marín, et al.
Page
of 57
Search research articles
Search
Showing results (551-560 of 568) with videos related to
Sort By:
Page
of 57
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
June 15, 2025
Psychomotor Development in Infants Following Maternal Exposure to Biologics: Results From the DUMBO Registry
Laura Palomino, Marta Velasco Rodríguez-Belvís, María José Casanova, et al.
Alimentary Pharmacology & Therapeutics
|
June 10, 2026
Real-World Effectiveness of Risankizumab in Refractory Crohn's Disease: The RISANCROHN Study From the ENEIDA Registry
Manuel Barreiro-de Acosta, Yamile Zabana, Laura Nieto-García, et al.
Journal of Clinical Medicine
|
July 29, 2023
Benefits of Paediatric to Adult Transition Programme in Inflammatory Bowel Disease: The BUTTERFLY Study of GETECCU and SEGHNP
Cristina Rubín de Célix, Javier Martín-de-Carpi, Gemma Pujol-Muncunill, et al.
The American Journal of Gastroenterology
|
January 30, 2023
Real-World Evidence of Tofacinitib in Ulcerative Colitis: Short-Term and Long-Term Effectiveness and Safety
María Chaparro, Diana Acosta, Cristina Rodríguez, et al.
United European Gastroenterology Journal
|
December 6, 2025
Comparative Study on the Management and Outcomes of Postoperative Crohn's Disease in Older Patients: Data From the ENEIDA Registry
Míriam Mañosa, Margalida Calafat, Elena Ricart, et al.
Inflammatory Bowel Diseases
|
February 15, 2022
Long-Term Real-World Effectiveness and Safety of Ustekinumab in Crohn's Disease Patients: The SUSTAIN Study
María Chaparro, Iria Baston-Rey, Estela Fernández-Salgado, et al.
Journal of Crohn'S & Colitis
|
May 8, 2019
Clinical Characteristics, Associated Malignancies and Management of Primary Sclerosing Cholangitis in Inflammatory Bowel Disease Patients: A Multicentre Retrospective Cohort Study
Ivan Guerra, Luis Bujanda, Jesús Castro, et al.
Journal of Clinical Medicine
|
August 12, 2022
Using Interpretable Machine Learning to Identify Baseline Predictive Factors of Remission and Drug Durability in Crohn's Disease Patients on Ustekinumab
María Chaparro, Iria Baston-Rey, Estela Fernández Salgado, et al.
Alimentary Pharmacology & Therapeutics
|
August 8, 2025
Frequency and Effectiveness of Dose Escalation and De-Escalation of Biologic Therapy in Inflammatory Bowel Disease: The RAINBOW-IBD Study of ENEIDA
Cristina Rubín de Célix, Elena Ricart, M Dolores Martín-Arranz, et al.
Alimentary Pharmacology & Therapeutics
|
June 29, 2024
Need for therapeutic escalation in patients with refractory ulcerative proctitis: Results from the PROCU study of the ENEIDA registry
Rocío Ferreiro-Iglesias, Sol Porto Silva, Sandra Marín, et al.
Page
of 57